Gilda da Cunha Santos

Author

Also Known As

G C Santos, G da C Santos, G. C. Santos, G. D. C. Santos, G. Da Cunha Santos, G. Santos, G. da Cunha Santos, G.C. Santos, G.D.C. Santos, GS Santos

125

Publications

7.3K

Citations

H-Index

Concepts

All Affiliations

University Health Network University of Toronto Princess Margaret Cancer Centre Universidade Federal de São Paulo Ontario Institute for Cancer Research

About

Gilda da Cunha Santos is an author at University Health Network specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	1.6K
2	Health Sciences	6	6	528
3	Engineering	3	3	138
4	Public Health	2	2	128
5	Social Sciences	1	1	30

Gilda da Cunha Santos

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome Ming‐Sound Tsao, Akira Sakurada, Jean-Claude Cutz, New England Journal of Medicine	2005	1.8K
Role of <i>KRAS</i> and <i>EGFR</i> As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 Chang‐Qi Zhu, Gilda da Cunha Santos, Keyue Ding, Journal of Clinical Oncology	2008	665
A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer Kazuhiro Yasufuku, Andrew Pierre, Gail Darling, Journal of Thoracic and Cardiovascular Surgery MedicineMediastinal LymphThoracic UltrasoundInterventional RadiologySurgery	2011	545
Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer Chétana Lim, Ming‐Sound Tsao, Lisa W. Le, Annals of Oncology Biomarker (Medicine)Prognostic BiomarkersOncologyHealth SciencesAdvanced Lung Disease	2015	234
First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial Cesare Gridelli, Fortunato Ciardiello, Ciro Gallo, Journal of Clinical Oncology	2012	232
A clinicopathologic study of 196 intraoral minor salivary gland tumours Márcio Ajudarte Lopes, Luiz Paulo Kowalski, Gilda da Cunha Santos, Journal of Oral Pathology and Medicine Retrospective StudySurgical OncologyTumoral PathologyMedicineSão Paulo	1999	164
Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer Gilda da Cunha Santos, Neesha C. Dhani, Dongsheng Tu, Cancer	2010	156
Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society Sinchita Roy‐Chowdhuri, Dara L. Aisner, Timothy Craig Allen, Archives of Pathology & Laboratory Medicine EngineeringPathologyBiomarker TestingTumor BiologyOncology	2016	104
Predictive and Pharmacodynamic Biomarker Studies in Tumor and Skin Tissue Samples of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Erlotinib Mark Agulnik, Gilda da Cunha Santos, David W. Hedley, Journal of Clinical Oncology PathologyDermatologyTumor BiologyPharmacodynamic Biomarker StudiesOncology	2007	96
FISH assay development for the detection of <i>p16/CDKN2A</i> deletion in malignant pleural mesothelioma Catherine T. Chung, Gilda da Cunha Santos, David Hwang, Journal of Clinical Pathology	2010	93

Page 1